Research News and Research

RSS

Patients with high blood pressure have benign endocrine tumours in adrenal gland: Research

High blood pressure may in some cases be caused by benign hormone-producing tumours of the adrenal cortex. A joint Swedish-American research effort has now uncovered a genetic cause behind the occurrence of such tumours. The findings were published today in the journal Science.

11 Feb 2011

HHS lists GE PSO as part of AHRQ Patient Safety Organization program

The Secretary of Health and Human Services has listed the GE-MERS National Patient Safety Organization as part of the Agency for Healthcare Research and Quality's Patient Safety Organization program. With this federal certification, GE Healthcare Performance Solutions joins leading healthcare organizations across the U.S. working to minimize risks in patient care.

11 Feb 2011

Food prices increased significantly in 2010, WFP data shows

Data from the World Food Program - available ahead of the release of its annual report - shows the cost of feeding people around the world "increased markedly in 2010 as rising grain prices pushed up the cost of staple foods," the Wall Street Journal reports.

11 Feb 2011

Bradmer Pharmaceuticals records net loss of $117,000 for fourth quarter of 2010

Bradmer Pharmaceuticals Inc. today announced its 2010 fourth quarter and fiscal year operational and financial results.

10 Feb 2011

State roundup: Arizona Medicaid waiver; Mass. BCBS plans charge more for high-cost hospitals; Texas Dems' abortion fight

Arizona Governor Jan Brewer's proposal to cut 280,000 people from the state's Medicaid rolls is being reviewed by U.S. officials who don't know whether they have the power to approve the action, Health and Human Services Secretary Kathleen Sebelius said.

10 Feb 2011

Scientists discover new method for early diagnosis, treatment of plaque-related diseases

UC Santa Barbara scientists have made a discovery that has the potential for use in the early diagnosis and eventual treatment of plaque-related diseases such as Alzheimer's disease and Type 2 diabetes. Their work is published in a recent issue of Nature Chemistry.

10 Feb 2011

DOPAL plays key role in killing dopamine neurons which trigger Parkinson's disease: Study

In new research from Saint Louis University, investigators have found evidence that a toxin produced by the brain is responsible for the series of cellular events that lead to Parkinson's disease. The study, published in PLoS One, found that the brain toxin DOPAL plays a key role in killing the dopamine neurons which trigger the illness.

10 Feb 2011

Presence of jumping genes, amplified oncogenes may be key to tumor progression: Researchers

The Massachusetts General Hospital research team that first discovered tumor-associated RNA in tiny membrane-enclosed sacs released into the bloodstream by cancer cells has now found that these microvesicles also contain segments of tumor DNA, including retrotransposons - also called "jumping genes" - that copy and insert themselves into other areas of the genome.

10 Feb 2011

House Republicans unveil partial list of budget cuts, advance plan to offer amendments to 'defund' health law

The National Journal reports on speculation that the GOP decision to advance a "clean" continuing resolution may signal that the Republican leadership is trying to move away from the partisan fight surrounding efforts to repeal the health law.

10 Feb 2011

New model of dementia care reduces emergency department visits, hospitalizations

An innovative model of dementia care developed by researchers at the Indiana University School of Medicine and the Regenstrief Institute significantly reduces emergency department visits and hospitalizations, and encourages use of medications that are not harmful to older brains. The result is improved health for older adults and their family caregivers and lower healthcare costs, according to a paper evaluating the model in real world use.

10 Feb 2011

Medivir initiates phase 1a clinical trial of TMC649128 for chronic HCV infection

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announces the start of a phase 1a clinical trial with TMC649128 intended for the treatment of chronic hepatitis C virus infection.

10 Feb 2011

College health plans must comply with health law's 'central provisions'

The Department of Health and Human Services made clear Wednesday that the nation's colleges and universities would not be exempt from the requirements of the health overhaul.

10 Feb 2011

Global Health Consortium to support development of vaccines to control dengue fever

The International Vaccine Institute today announced the launch of the Dengue Vaccine Initiative, in collaboration with the Sabin Vaccine Institute, the Johns Hopkins University, and the World Health Organization, to support development of vaccines to control dengue fever, a widespread and expanding hemorrhagic fever that is endemic in most tropical and subtropical regions of the world.

10 Feb 2011

Genta initiates new Phase 2 clinical trial of tesetaxel in patients with advanced prostate cancer

Genta Incorporated today announced that the Company has initiated a new Phase 2 clinical trial of tesetaxel in patients with advanced prostate cancer. Tesetaxel, the leading oral taxane in clinical development, will be evaluated for its use as both first- and second-line chemotherapy.

10 Feb 2011

Guide designed to help hospitals reduce variation in care

The American Hospital Association has released a guide to help hospitals and health care systems reduce inappropriate variation in areas such as end-of-life care, imaging, emergency services and obstetrics.

10 Feb 2011

Researchers find significant association between childhood physical abuses, peptic ulcers

Victims of childhood physical abuse are more than twice as likely to develop ulcers than people who were not abused as children, according to a new study from researchers at the University of Toronto.

10 Feb 2011

Analyst offers prediction about Medicare advantage plans

Initial 2012 reimbursement rates for Medicare Advantage plans should be roughly flat, which tops the consensus expectation of a 2 percent drop, according to Citi analyst Carl McDonald. McDonald said Tuesday in a research note the rates will be hurt by cuts from the health care overhaul, but he also thinks they will benefit from an adjustment to prior estimates.

10 Feb 2011

Research News and Research

Patients with high blood pressure have benign endocrine tumours in adrenal gland: Research

HHS lists GE PSO as part of AHRQ Patient Safety Organization program

Food prices increased significantly in 2010, WFP data shows

Bradmer Pharmaceuticals records net loss of $117,000 for fourth quarter of 2010

State roundup: Arizona Medicaid waiver; Mass. BCBS plans charge more for high-cost hospitals; Texas Dems' abortion fight

Scientists discover new method for early diagnosis, treatment of plaque-related diseases

DOPAL plays key role in killing dopamine neurons which trigger Parkinson's disease: Study

Presence of jumping genes, amplified oncogenes may be key to tumor progression: Researchers

House Republicans unveil partial list of budget cuts, advance plan to offer amendments to 'defund' health law

New model of dementia care reduces emergency department visits, hospitalizations

Medivir initiates phase 1a clinical trial of TMC649128 for chronic HCV infection

College health plans must comply with health law's 'central provisions'

Global Health Consortium to support development of vaccines to control dengue fever

Genta initiates new Phase 2 clinical trial of tesetaxel in patients with advanced prostate cancer

Guide designed to help hospitals reduce variation in care

Researchers find significant association between childhood physical abuses, peptic ulcers

Analyst offers prediction about Medicare advantage plans

NeoGenomics fourth quarter revenue increases 12% to $8.8 million

First Edition: February 10, 2011

Momenta reports fourth quarter 2010 net income of $36.3M vs. $14.7M net loss for fourth quarter 2009

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Latest eBooks

New horizons in drug discovery: High-throughput & target-to-therapy advances

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology